Latest Breaking News On - Pherecydes pharma - Page 21 : comparemela.com
Phage Therapy Market is Going to Boom with Locus Biosciences, Armata Pharmaceuticals, Micreos
sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.
More bacteria are becoming resistant to antibiotics – here s how viruses and vaccines could help – Horizon Magazine Blog
scienceblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scienceblog.com Daily Mail and Mail on Sunday newspapers.
Pherecydes Pharma Will Present Its Work on the Provision of Bacteriophages for Therapeutic Use at the France Bioproduction Congress
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Bacteriophages Therapy Market 2021 Analysis by Top Manufacturers – Adaptive Phage Therapeutics, Intr
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Pherecydes Pharma expands its patent portfolio with a new patent granted in Hong Kong
NANTES, France (BUSINESS WIRE) Regulatory News:
Pherecydes Pharma (Paris:ALPHE) (FR0011651694 - ALPHE), a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, today announced that the Hong Kong authorities have granted a patent for its anti-
Pseudomonas Aeruginosa phages in that jurisdiction.
This patent, as well as those already granted in the United States, Israel, Japan, Europe and Australia, protect Pherecydes Pharma’s intellectual property through to the end of 2034.
Guy-Charles Fanneau de La Horie, Chairman of the Executive Board of Pherecydes Pharma, said: “